TCL Archive Von Eschenbach takes leave of absence from NCI, resigns from C-Change board. Acting FDA commissioner’s drug approval strategy rooted in unproven science. Von Eschenbach told NCI deputies he might drop in on meetings. Who’s really in charge? By Cancer History Project October 7, 2005
TCL Archive John Niederhuber named NCI chief operating officer; the surgeon was asked to leave two previous positions. By Cancer History Project October 7, 2005
TCL Archive Cancer death rate dropping 1.1 percent a year, annual report finds. By Cancer History Project October 7, 2005
TCL Archive White House appoints NCI Director Andrew von Eschenbach acting FDA commissioner after Lester Crawford resigns. By Cancer History Project September 30, 2005
TCL Archive ASCO Backs Sentinel Node Biopsy In Some Early Stage Breast Cancer By Cancer History Project September 30, 2005
TCL Archive Breast Cancers Detected By Mammograms Have Better Prognosis, Trials Analysis Finds By Cancer History Project September 30, 2005
TCL Archive Von Eschenbach says he will continue as NCI director and give both jobs “100 percent.” By Cancer History Project September 30, 2005
Article Fran Visco tells the story of NBCC: “Women have declared war on breast cancer” By Cancer History Project
